Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Mounjaro 5mg KwikPen
Manufacturer/Marketed By : ELI LILLY AND COMPANY INDIA PVT LTD
$174.70 $143.74
Mounjaro is a GLP-1 receptor agonist intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose levels. The Mounjaro 5 mg KwikPen...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TIRZEPATIDE
Active Pharmaceutical Ingredient
Mounjaro 5mg KwikPen
174,70$
143,74$
Mounjaro is a GLP-1 receptor agonist intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose levels. The Mounjaro 5 mg KwikPen is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength :for example, a 5 mg pen holds a total of 20 mg of tirzepatide (4 doses × 5 mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. Many patients often ask how many doses are in Mounjaro 5 mg KwikPen, and some also wonder whether it’s safe to take a different dose from a Mounjaro 5 mg KwikPen. It’s important to follow the prescribed dosage exactly and not adjust doses manually, as the pen delivers fixed, pre-measured doses to ensure safe and effective blood-sugar control. This GLP-1 medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider.
Active Pharmaceutical Ingredient
Uses
• Improves blood sugar control in adults with type 2 diabetes mellitus through the action of a GLP-1 receptor agonist.
• Used in combination with diet and exercise for better glycaemic management.
• This GLP-1 medication may be used alone or together with other diabetes medicines, as prescribed by a healthcare provider.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Common Side Effects:
Most Common Side Effects
• Pancreatitis (severe abdominal pain)
• Gallbladder issues (pain in the upper right abdomen)
• Allergic reactions (rash, swelling, difficulty breathing)
• Kidney problems due to dehydration from vomiting or diarrhea
• Thyroid tumors (rare but serious; watch for neck swelling or hoarseness)
Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Constipation
• Decreased appetite
• Injection site reactions (redness, itching)
How To Use
Inject once weekly into your abdomen, thigh, or upper arm, with or without food, at any time of the day. Always try to use it on the same day each week. Remember:
Safety Advice
• Pregnancy: Mounjaro 5mg KwikPen is not recommended during pregnancy due to limited human data. Animal studies show potential harm.
• Breast Feeding: It is unknown whether tirzepatide passes into breast milk. Mounjaro 5mg KwikPen should only be used if clearly needed.
• Lungs: Mounjaro 5mg KwikPen is not known to affect the lungs directly, but if you have respiratory conditions, inform your doctor before use.
• Liver: Mounjaro 5mg KwikPen should be used cautiously in people with liver conditions. Regular liver function monitoring may be required.
• Alcohol: Drinking alcohol while using Mounjaro 5mg KwikPen may increase the risk of low blood sugar. Limit alcohol intake.
• Driving: Mounjaro 5mg KwikPen can occasionally cause low blood sugar, which may impair focus or coordination while driving.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.